A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Page Count: 47
Table of Contents
Market Analysis
Overview of IVD Immunoassay
Market Outlook
Major Product Activity
Company Briefs
Abbott Diagnostics
Roche
Siemens Healthineers
Executive News Briefing
Briefs
OpGen Closes $3.38 Million in Direct Offering
Cue Health Appoints New CCO
Pleno Receives $40 million in Series A
Exact Sciences’ Revenues Supported by Screening Revenues
Sekisui Chemical Reports Double Digit Growth in All Business Segments During Q1 FY22
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
Partnerships and Collaborations
Industry Watch
Virus Testing Update
Region Watch
Italy
New Zealand
Singapore
Broad-based Company Announcements
Biocartis Commercializes HepatoPredict Test in Europe
Fujirebio Markets Self-Screening Cervical Cancer Test in Europe
Molecular Diagnostics could be said to be the most important part of in vitro diagnostics. This is especially true in the wake of COVID-19. Kalorama Information has, for many years, estimated the size of and forecasted the growth of the worldwide…
